Navigation Links
Gerresheimer Substantially Increases Quarterly Operating Profit
Date:10/15/2008

DUSSELDORF, Germany, October 15 /PRNewswire-FirstCall/ --

- Sales in the Third Quarter up by 7.2% to EUR268.0m

- Adjusted Group Results More Than Doubled in the Third Quarter of 2008 From EUR7.4m to EUR16.5m

- Sales Process Started for Technical Plastics Business

- CEO Dr. Axel Herberg Confirms the Outlook for 2008

Gerresheimer AG again achieved a substantial increase in sales and operating results in the third quarter of 2008. Overall, sales by the globally operating manufacturer of special products for the pharma & life science industry totalled EUR268.0m (Q3 2007: EUR250.1m). This is equivalent to growth of 7.2%. On a like-for-like exchange-rate basis sales actually increased by 10.2%. Operating results (Adjusted EBITDA) improved by 14.1% to EUR50.3 m (prior year: EUR44.1m). The adjusted EBITDA margin increased to 18.8% from 17.6%. In the third quarter the sale process for the Technical Plastics business was commenced. This led to non-scheduled depreciation of EUR33.0m, resulting in a negative consolidated result of EUR22.8m for the third quarter. Gerresheimer takes this charge in anticipation of the possible book loss on the sale. The depreciation has no effect on cash flow or operating results. The adjusted net income, which reflects the company's operating profitability, more than doubled in comparison with the prior-year quarter to EUR16.5m (Q3 2007: EUR7.4m). The same applies for adjusted earnings per share, which were substantially higher in the third quarter of 2008 at EUR0.52 (Q3 2007: EUR0.22).

"By focussing on the markets of pharma & life science we have again realised above-average growth this quarter. Gerresheimer is bucking the current negative trend in the global economy and shows that we are a strong company which continues to grow profitably even in difficult times," says Dr. Axel Herberg, Chief Executive Officer of Gerresheimer AG.

The positive result for the third quarter of 2008 is also re
'/>"/>

SOURCE Gerresheimer AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Gerresheimer Starts Process to Sell off its Business Segment of Technical Plastics
2. Gerresheimer Further Increases its Sales and Earnings Power
3. Gerresheimer Discontinues Marginal Operations
4. Moodys Raises Rating for Gerresheimer
5. Gerresheimer: Record Year in 2007 and Positive Outlook for 2008
6. 2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer
7. Yves Lionel Assant is New Chairman of Gerresheimers Supervisory Board
8. AFFiRiS - MIG-Fonds Increases Investment by Euro 3 Million
9. OncoGenex increases economic interest in lead cancer drug OGX-011
10. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
11. New Dual Cold Probe From Varian, Inc. Increases Sensitivity and Reduces Analysis Times for 13C NMR Experiments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 This webinar will focus on ... safety assessment in biosimilars. , Regulatory frameworks are evolving ... development, however the complex nature of biopharmaceuticals makes the ... efficacy extremely challenging. Based on the specific aspects of ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 The Microcompetition with ... major disease. One of these latent viruses is the Epstein ... arthritis (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease ... a study found that RA patients have high concentrations of ...
(Date:1/15/2014)... 15, 2014 AudioNotch is the internet's ... for the treatment of tinnitus. Patients listen to sound ... over a period of weeks to months, their tinnitus volume ... two forms: Notched Music and Notched White Noise. Now, AudioNotch ...
(Date:1/14/2014)... 2014 Histogen, Inc., a regenerative medicine ... grown under simulated embryonic conditions, today announced that they ... Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary ... agreement is an amendment to the existing license between ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that ... company update at the Deutsche Bank 34th Annual Health Care ... p.m. ET. Interested parties may access a live audio ... the BioMarin website, www.BMRN.com . A ...
... platform for treatment of Spinal Muscular Atrophy SOUTH PLAINFIELD, ... Inc. (PTC) and the Spinal Muscular Atrophy (SMA) Foundation ... which the SMA Foundation will provide up to $8.5 ... second continuation of the collaboration to fund a series ...
... AND STRENGTHENS ITS SENIOR MANAGEMENT TEAM , ... Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in ... today announced that it has strengthened its European presence ... Summa. As Executive Vice President, Europe & Asia/Pacific based ...
Cached Biology Technology:BioMarin to Present at the Deutsche Bank Health Care Conference 2PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration 2PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration 3OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific 2OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific 3
(Date:7/10/2014)... and teens living with a cardiac pacemaker, a low ... of life, reports a study in the July ... the official journal of the Society for Developmental ... by Lippincott Williams & Wilkins , a part ... function as a protective factor against lower health-related quality ...
(Date:7/10/2014)... image was collected by the Moderate Resolution Imaging Spectroradiometer ... Each hot spot, which appears as a red mark, ... MODIS instrument recognized temperatures higher than background. When accompanied ... hot spots are diagnostic for fire. , This ... coming directly from the fires, although the smoke released ...
(Date:7/10/2014)... some patients, the chronic inflammatory skin diseases psoriasis* and ... have therefore had to base their decision on which ... an examination of tissue samples. A team of researchers ... of Munich (TUM) have now analyzed the molecular processes ... This has enabled them for the first time to ...
Breaking Biology News(10 mins):For children with pacemakers, 'self-competence' affects quality of life 2New diagnostic test to distinguish psoriasis from eczema 2
... Science-based identification of mold and other causes of ... plant pathologists with The American Phytopathological Society (APS). ... situation in which building occupants experience health problems ... typically associated with SBS range from allergy attacks ...
... South Korean team announced last week that it had ... that were genetically matched to specific people. But their ... Yuri Verlinsky of the Reproductive Genetics Institute, based in ... without resorting to therapeutic cloning. "It would be a ...
... When genes are deleted on a particular section of ... the childhood cancer neuroblastoma. A new study suggests that ... children with neuroblastoma may indicate to physicians that they ... fight the cancer. , Edward F. Attiyeh, M.D., a ...
Cached Biology News:What's really making you sick? Plant pathologists offer the science behind Sick Building Syndrome 2Double triumph in stem cell quest 2Double triumph in stem cell quest 3Double triumph in stem cell quest 4Chromosome Deletion Predicts Aggressive Neuroblastoma 2
... Glutathion-S-Transferase-pi EIA Principle: Glutathion-S-transferases ... which are involved in the detoxification ... 5 subgroups: Alpha, Mu, Pi, Teta ... their physiochemical, immunological, enzymatic and s ...
... only microplate sealer with an integrated in-line ... with a variety of configurations and sealing ... integrated stacker and 240-plate storage capacity , ... in small workcells , Handles all SBS ...
... aptamer screening and binding optimization and built ... on-chip synthesis platform. These microarrays are available ... Microarray Service. Probe Content ... than 1500 known aptamer sequences. Add up ...
... Microarrays designed for RNA aptamer screening and ... and powerful Paraflo microfluidic on-chip synthesis platform. ... be synthesized on-chip and LC Sciences can ... microarrays are available as part of our ...
Biology Products: